Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-10-09
2007-10-09
Le, Long V. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C424S184100, C424S185100, C424S275100, C424S276100, C435S007100, C435S007950, C435S069300, C435S975000, C436S518000, C436S536000, C436S543000, C530S370000
Reexamination Certificate
active
10400071
ABSTRACT:
The present invention relates to a novel allergen from timothy grass (Phleum pretense) pollen, Phl p11 as disclosed in SEQ ID NO:2, and use thereof as a reagent and in a diagnositic kit as well as for immunotherapy.
REFERENCES:
patent: 03/047618 (2003-06-01), None
D'Amato, G. et al.; “Position paper, Pollen-related allergy in Europe”;ALLERGY; Munksgaard 1998,53, pp. 567-578.
Esch, Robert E.; “Grass Pollen Allergens”;Allergen and Allergen Immunotherapy, Second Edition, Revised and Expanded; Marcel Dekker, Inc., New York, 1999, pp. 103-120.
Laffer, Sylvia et al.; “Complementary DNA cloning of the major allergen Phl p I from timothy grass (Phleum pratense); recombinant Phl p I inhibits IgE binding to group I allergens from eight different grass species”;J Allergy Clin Immunol, Oct. 1994, 94, 4, pp. 689-698.
Petersen, Arnd et al.; “Structural investigations of the major allergen Phl p I on the complementary DNA and protein level”;J Allergy Clin Immunol, May 1995, 95, 5, 1, pp. 987-994.
Dolecek, Christiane et al.; “Molecular characterization of Phl p II, a major timothy grass (Phleum pratense) pollen allergen”;FEBS Letters; Dec. 1993, 35, 3, pp. 299-304.
Vrtala, Susanne et al.; “cDNA Cloning of a Major Allergen from Timothy Grass (Phleum pratense) Pollen; Characterization of the Recombinant Phl p V Allergen”;The Journal of Immunology; Nov. 1993, 151, 9, pp. 4773-4781.
Bufe, Albrecht et al.; “Major allergen Phl p Va (timothy grass) bears at least two different IigE-reactive epitopes”;J Allergy Clin Immunol; Aug. 1994, 94, 2, pp. 173-181.
Bufe, A. et al.; “Major allergen Phl p Vb in timothy grass is a novel pollen Rnase”;FEBS Letters 363; 1995, pp. 6-12.
Petersen, A. et al.; “Characterization of the Allergen Group VI in Timothy Grass Pollen (Phl p 6); cDNA Cloning of Phl p 6 and Structural Comparison to Grass gGroup V”;Int Arch Allergy Immunol; 1995, 108, pp. 55-59.
Vrtala, Susanne et al.; “Molecular, Immunological, and Structural Characterization of Phl p 6, a Major Allergen and P-Particle-Associated Protein from Timothy Grass (Phleum pratense) Pollen”;Characterization of a Major Timothy Grass Pollen Allergen, Phl p 6; 1999, pp. 5489-5496.
Niederberger, Verena et al.; “Calcium-dependent immunoglobulin E recognition of the apo- and calcium—bound form of a cross-reactive two EF-hand timothy grass pollen allergen, Phl p 7”;The FASEB Journal; May 1999, 13, pp. 843-856.
Valenta, Rudolf et al.; “cDNA cloning and expression of timothy grass (Phleum pratense) pollen profiling inEscherichia coli: comparison with birch pollen prolifin”;Biological and Biophysical Research Communications; Feb. 1994, 199, 1, pp. 106-117.
Suck, R. et al.; “Complementary DNA cloning and expression of a newly recognized high molecular mass allergen Phl p 13 from timothy grass pollen (Phleum pratense)”;Clinical and Experimental Allergy; 2000, 30, pp. 324-332.
Niederberger, Verena et al.; “IgE antibodies to recombinant pollen allergens (Phl p1, Phl p 2, Phl p 5 and Bet v 2) account for a high percentage of grass pollen-specific IgE”;J Allergy Clin Immunol; 1998, 101, pp. 258-264.
Valenta, Rudolf et al.; “Identification of Profilin as a Novel Pollen Allergen; IgE Autoreactivity in Sensitized Individuals”;Science; 253, pp. 557-560.
Valenta, Rudolf et al.; “Prolifins Constitute a Novel Family of Functional Plant Pan-allergens”,J. Exp. Med.; Feb. 1992, 175, pp. 377-385, 1991.
Ball, Tanja et al.; “Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy”;Eur. J. Immunol; 1999, 29, pp. 2026-2036.
Chirgwin, John M. et al.; “Isolation of Biologically Active Ribonucleic Acid from Sources Enriched in Ribonuclease”;Isolation of RNA with Guanidinum Thocyanate; 1979, 18, 24, pp. 5294-5299.
Innis, M. A. et al.; “Rapid Amplification of Complementary DNA Ends for Generation of Full-Length Complementary DNAs: Thermal RACE”;PCR for Amplifying and Manipulating DNA; 1993, 218, pp. 340-356.
Crosa, Jorge H. et al.; “Construction and Characterization of New Cloning Vehicles; A Multipurpose Cloning System”;GENE; 1977, 2, pp. 95-113.
Valent, P. et al.; “Interleukin 3 activates human blood basophils via high-affinity binding sites”;Proc. Natl. Acad. Sci.; Jul. 1989, 86, pp. 5542-5546.
Valenta, Rudolf et al.; “Induction of specific histamine release from basophils with purified natural and recombinant birch pollen allergens”;J Allergy Clin Immunol; 91, 1, pp. 88-97, 1993.
Vrtala, Susanne et al.; “Conversion of the Major Birch Pollen Allergen, Bet v 1, into Two Nonanaphylactic T Cell Epitope-containing Fragments, Candidates for a Novel Form of Specific Immunotherapy”;Recombinant Nonanaphylactic Bet v 1 Fragments for Immunotherapy; Apr. 1997, 99, 7, pp. 1673-1681.
Van Ree, Ronald et al.; “Lol p XI, a new major grass pollen allergen, is a member of a family of soybean trypsin inhibitor-related proteins”;J Allergy Clin Immunol; 1995, 95, 5, pp. 970-978.
Calabozo, B. et al.; “Structural and Antigenic Similarity Between PLA L 1 and Ole E 1, the major Allergens of English Plantain and Olive Pollens”,The Journal of Allergy and Clinical Immunology; Feb. 2001, 107, 2, p. S15.
Valenta, R. et al.; “The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT)”;Clinical and Experimental Allergy; 1999, 29, pp. 896-904.
Mertens, Nico et al.; “Tight Transcriptional Control Mechanism Ensures Stable High-Level Expression from T7 Promoter-Based Expression Plasmids”;Bio/Technology; Feb. 1995, 13, pp. 175-179.
Van Der Veen, Maurita J. et al.; “Allergens, IgE, mediators, inflammatory mechanisms, Poor biologic activity of cross-reactive IgE directed to carbohydrate determinants of glycoproteins”;J Allergy Clin Immunol; Sept. 1997, 100, 3, pp. 327-334.
Aalberse, R. C. et al.; “Crossreactive Carbohydrate Determinants”;Clinical Reviews in Allergy and Immunology; 1997, 15, pp. 375-387.
Aalberse, R.C.; “Clinical relevance of carbohydrate allergen epitopes”;Allergen; 1998, 53, pp. 54-57.
Mari, Adriano et al.; “Specific IgE to cross-reactive carbohydrate determinants strongly affect the in vitro diagnosis of allergic diseases”;J Allergy Clin Immunol; Jun. 1999, 103, pp. 1005-1011.
Van Ree, Ronald et al.; “Specific IgE without clinical allergy”;J Allergy Clin Immunol; 103, 6, pp. 1000-1001, 1999.
Barderas, Rodrigo et al.; “Isolation and Cloning of Che a 1, Allergen From Chenopodium Album Pollen”;J Alergy Clin Immunol;; 107, 2, p. S19, 2001.
Lehtonen Pirjo
Lidholm Jonas
Marknell Dewitt Asa
Niederberger Verena
Sperr Wolfgang R.
Grun James L.
Le Long V.
Phadia AB
LandOfFree
Allergen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Allergen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Allergen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3839997